OEM Supply Tiratricol Drugs - Chlorogenic acid – Chenlv Detail:
CAS No.: 327-97-9
Latin name: Eucommiae Cortex
Part used: leaf
Test method: HPLC
Appearance: White fine powder
Molecular Formula: C16H18O9
Molecular Weight: 354.31
Specification: Chlorogenic acid98%
FUNCTION:
1.Chlorogenic acid has obvious antihypertensive effect, but its curative effect is stable and has no toxic and side effects.
2.Antitumor effect: it has the effect of preventing and treating nasopharyngeal carcinoma, has the remarkable effect of treating tumor, and has the characteristics of low toxicity and safety. Japanese scholars study that chlorogenic acid has the effect of anti-mutation, which reveals the preventive effect of chlorogenic acid on tumor.
3.Tonifying the kidney and enhancing the immune effect of the body;
4.Antioxidant, anti-aging, resistance such as bone aging;
5.Anti-bacterial, antiviral, diuretic, choleretic, hypolipidemic and fetus-protecting effects;
6.The health-care food can make the health-care food sweet and delicious, has the characteristics of clearing away heat and toxic materials, caring skin and moistening skin, and relieving smoking.
Product packing: 25kg/drum
Validity period: 2 years
Product detail pictures:
Related Product Guide:
Our products are widely recognized and trusted by users and can meet continuously changing economic and social needs for OEM Supply Tiratricol Drugs - Chlorogenic acid – Chenlv, The product will supply to all over the world, such as: Bangladesh , Anguilla , Qatar , With the effort to keep pace with world's trend, we will always endeavor to meet customers' demands. If you want develop any other new products, we can customize them for you. If you feel interest in any of our products or want develop new products, please feel free to contact us. We are looking forward to forming successful business relationship with customers all over the world.
By Stephanie from Munich - 2018.06.03 10:17
It is a very good, very rare business partners, looking forward to the next more perfect cooperation!
By Alan from Chile - 2018.02.08 16:45